Cita APA (7a ed.)

P, H., E, B., JB, H., & M, A. (2021). Efficacy of Brodalumab and Guselkumab in Patients with Moderate-to-Severe Plaque Psoriasis Who are Inadequate Responders to Ustekinumab: A Matching Adjusted Indirect Comparison. Dove Medical Press.

Cita Chicago Style (17a ed.)

P, Hampton, Borg E, Hansen JB, y Augustin M. Efficacy of Brodalumab and Guselkumab in Patients with Moderate-to-Severe Plaque Psoriasis Who Are Inadequate Responders to Ustekinumab: A Matching Adjusted Indirect Comparison. Dove Medical Press, 2021.

Cita MLA (8a ed.)

P, Hampton, et al. Efficacy of Brodalumab and Guselkumab in Patients with Moderate-to-Severe Plaque Psoriasis Who Are Inadequate Responders to Ustekinumab: A Matching Adjusted Indirect Comparison. Dove Medical Press, 2021.